Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis
Clinical trial NCT03198689 · COMPLETED
Trial details
- NCT number
- NCT03198689
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-07
- Primary completion
- 2023-06-07
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.